Skip to content
10-Q

Quarterly Report

MEDICUS SCIENCES ACQUISITION CORP.

0001104659-22-118537

← back to feed
Filed
Nov 14, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$457.2K
Cash And Equivalents Q3 2022 · Sep 30, 2022 $976.56K
Cash And Equivalents Q3 2022 · Dec 31, 2021 $1.43M
Stockholders Equity Q3 2022 · Sep 30, 2022 −$2.82M
Stockholders Equity Q3 2022 · Jun 30, 2022 −$2.91M
Stockholders Equity Q3 2022 · Mar 31, 2022 −$4.39M
Stockholders Equity Q3 2022 · Dec 31, 2021 −$6.64M
Current Liabilities Q3 2022 · Sep 30, 2022 $55.41K
Current Liabilities Q3 2022 · Dec 31, 2021 $32.01K
Total Liabilities Q3 2022 · Sep 30, 2022 $3.87M
Total Liabilities Q3 2022 · Dec 31, 2021 $8.27M
Current Assets Q3 2022 · Sep 30, 2022 $1.05M
Current Assets Q3 2022 · Dec 31, 2021 $1.58M
Total Assets Q3 2022 · Sep 30, 2022 $93.43M
Total Assets Q3 2022 · Dec 31, 2021 $93.62M
Net Income Q3 2022 · Sep 30, 2022 $382.83K
Net Income Q3 2022 · Sep 30, 2022 $4.21M
Net Income Q3 2022 · Jun 30, 2022 $1.57M
Net Income Q3 2022 · Mar 31, 2022 $2.25M
Operating Income Q3 2022 · Sep 30, 2022 −$174.13K
Operating Income Q3 2022 · Sep 30, 2022 −$558.2K